|
|
||||||||
AJP - Cell Physiology, Vol 270, Issue 1 C208-C213, Copyright © 1996 by American Physiological Society
ARTICLES |
J. K. Bubien, I. I. Ismailov, B. K. Berdiev, T. Cornwell, R. P. Lifton, C. M. Fuller, J. M. Achard, D. J. Benos and D. G. Warnock
Department of Medicine, University of Alabama at Birmingham, USA.
Liddle's disease is an autosomal dominant genetic disorder characterized by severe low renin hypertension ("pseudoaldosteronism") that has been genetically linked to a locus on chromosome 16 encoding the beta-subunit of an amiloride-sensitive Na+ channel (ASSC) (15). Peripheral blood lymphocytes (PBL) express ASSC that are functionally indistinguishable from those expressed by Na(+)-reabsorbing renal epithelial cells (3, 5). The amiloride-sensitive Na+ conductance in PBL from affected and unaffected individuals from the original Liddle's pedigree was examined using whole cell patch clamp. Typically, the basal Na+ currents in cells from affected individuals were maximally activated. Basal Na+ currents in cells from unaffected individuals were minimal and could be maximally activated by superfusion with 8-(4-chlorophenylthio)adenosine 3',5'-cyclic monophosphate (CPT-cAMP). Affected cells could not be further stimulated with CPT-cAMP. Superfusion with a supermaximal concentration of amiloride (2 microM) inhibited both the cAMP-activated Na+ conductance in unaffected cells and the constitutively activated inward conductance in affected cells. Cytosolic addition of a peptide identical to the terminal 10 amino acids of the truncated beta-subunit normalized the cAMP-mediated but not the pertussis toxin-induced regulation of the mutant ASSC. The findings show that lymphocyte ASSC are constitutively activated in affected individuals, that a mutation of the beta-subunit alters ASSC responsiveness to specific regulatory effectors, and that the cellular mechanism responsible for the pathophysiology of Liddle's disease is abnormal regulation of Na+ channel activity. These findings have important diagnostic and therapeutic implications and provide a cellular phenotype for the diagnosis of pseudoaldosteronism.
This article has been cited by other articles:
![]() |
F. Lang, V. Vallon, M. Knipper, and P. Wangemann Functional significance of channels and transporters expressed in the inner ear and kidney Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1187 - C1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Debigare and S. R. Price Proteolysis, the ubiquitin-proteasome system, and renal diseases Am J Physiol Renal Physiol, July 1, 2003; 285(1): F1 - F8. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Zhou and J. K. Bubien ENaC plays a role in regulated antibody secretion by hybridomas Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1480 - C1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kamynina and O. Staub Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na+ transport Am J Physiol Renal Physiol, September 1, 2002; 283(3): F377 - F387. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Ji, C. M. Fuller, and D. J. Benos Intrinsic gating mechanisms of epithelial sodium channels Am J Physiol Cell Physiol, August 1, 2002; 283(2): C646 - C650. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Carter, Z. H. Zhou, D. A. Calhoun, and J. K. Bubien Hyperactive ENaC identifies hypertensive individuals amenable to amiloride therapy Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1413 - C1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Zhou and J. K. Bubien Nongenomic regulation of ENaC by aldosterone Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1118 - C1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Brown Targeting of membrane transporters in renal epithelia: when cell biology meets physiology Am J Physiol Renal Physiol, February 1, 2000; 278(2): F192 - F201. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Ji, C. M. Fuller, and D. J. Benos Peptide Inhibition of Constitutively Activated Epithelial Na+ Channels Expressed in Xenopus Oocytes J. Biol. Chem., December 31, 1999; 274(53): 37693 - 37704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Persu, P. Barbry, F. Bassilana, A.-M. Houot, R. Mengual, M. Lazdunski, P. Corvol, and X. Jeunemaitre Genetic Analysis of the ß Subunit of the Epithelial Na+ Channel in Essential Hypertension Hypertension, July 1, 1998; 32(1): 129 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dinudom, K. F. Harvey, P. Komwatana, J. A. Young, S. Kumar, and D. I. Cook Nedd4 mediates control of an epithelial Na+ channel in salivary duct cells by cytosolic Na+ PNAS, June 9, 1998; 95(12): 7169 - 7173. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Adams, P. M. Snyder, and M. J. Welsh Interactions between Subunits of the Human Epithelial Sodium Channel J. Biol. Chem., October 24, 1997; 272(43): 27295 - 27300. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cui, Y. R. Su, M. Rutkowski, M. Reif, A. G. Menon, and R. Y. K. Pun Loss of protein kinase C inhibition in the beta -T594M variant of the amiloride-sensitive Na+ channel PNAS, September 2, 1997; 94(18): 9962 - 9966. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Bubien, B. Watson, M. A. Khan, A. L. B. Langloh, C. M. Fuller, B. Berdiev, A. Tousson, and D. J. Benos Expression and Regulation of Normal and Polymorphic Epithelial Sodium Channel by Human Lymphocytes J. Biol. Chem., March 9, 2001; 276(11): 8557 - 8566. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |